The main objective of this study was to demonstrate the non-inferiority of intravenous paracetamol relative to intravenous ketoprofen when treating renal colic in an emergency ward. Efficacy is measured by the change in verbal numeric scale (vns) for pain at 30 minutes.
The secondary objectives of this study are: * To compare the efficacy (non-inferiority) of intravenous paracetamol and ketoprofen at 90 minutes (vns for pain). * To compare both arms in terms of other administered drugs (for pain). * To observe and compare side effects between the two arms: cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine. * To determine predictors for the use of intravenous morphine when treating renal colic. * To compare hospitalization rates between the two groups. * To compare patient satisfaction concerning care between the two groups (vns for satisfaction) * To observe and compare changes towards complicated renal colic (obstructive pyelonephritis, hyperalgesia, urinary tract rupture, need for surgical drainage, sepsis, death)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Patients will recieve 100 mg of ketoprofen via slow intravenous perfusion. (100mg of ketoprofen powder for injection dissolved in 100 ml injectable isotonic solution)
Patients will receive 1g of paracetamol via slow intravenous perfusion. (100 ml of solution at 10mg/ml)
CH d'Alès
Alès, France
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, France
Change in vns for pain
Verbal numeric scale ranging from 0 to 10.0.
Time frame: baseline to 30 minutes
Change in vns for pain
Verbal numeric scale ranging from 0 to 10.0.
Time frame: baseline to 90 minutes
Quantity of (posology) tramadol administered
Time frame: baseline (minute 0)
Quantity of (posology) tramadol administered
Time frame: 30 minutes
Quantity of (posology) tramadol administered
Time frame: 90 minutes
Quantity of (posology) tramadol administered
Time frame: discharge from emergency ward (estimated max of 24 hours)
Quantity of (posology) phloroglucinol administered
Time frame: baseline (minute 0)
Quantity of (posology) phloroglucinol administered
Time frame: 30 minutes
Quantity of (posology) phloroglucinol administered
Time frame: 90 minutes
Quantity of (posology) phloroglucinol administered
Time frame: discharge from emergency ward (estimated max of 24 hours)
Was morphine administered? yes/no
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: baseline (minute 0)
Quantity of (posology) morphine administered
Time frame: 30 minutes
Quantity of (posology) morphine administered
Time frame: 90 minutes
Quantity of (posology) morphine administered
Time frame: discharge from emergency ward (estimated max of 24 hours)
Quantity of (posology) Nefopam administered
Time frame: baseline (minute 0)
Quantity of (posology) Nefopam administered
Time frame: 30 minutes
Quantity of (posology) Nefopam administered
Time frame: 90 minutes
Quantity of (posology) Nefopam administered
Time frame: discharge from emergency ward (estimated max of 24 hours)
Quantity of (posology) Alfuzosine administered
Time frame: baseline (minute 0)
Quantity of (posology) Alfuzosine administered
Time frame: 30 minutes
Quantity of (posology) Alfuzosine administered
Time frame: 90 minutes
Quantity of (posology) Alfuzosine administered
Time frame: discharge from emergency ward (estimated max of 24 hours)
Presence/absence of complications
cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine
Time frame: baseline (minute 0)
Presence/absence of complications
cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine
Time frame: 30 minutes
Presence/absence of complications
cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine
Time frame: 90 minutes
Presence/absence of complications
cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine
Time frame: week 1
Was the patient hospitalized? yes/no
Time frame: discharge from emergency ward (estimated max of 24 hours)
Was the patient hospitalized? yes/no
Time frame: week 1
VNS for patient satisfaction concerning care
Time frame: week 1
Evolution towards a complicated renal colic
Qualitative variable with the following classes: obstructive pyelonephritis, hyperalgesia, urinary tract rupture, need for surgical drainage, sepsis, death
Time frame: discharge from emergency ward (estimated max of 24 hours)
Evolution towards a complicated renal colic
Qualitative variable with the following classes: obstructive pyelonephritis, hyperalgesia, urinary tract rupture, need for surgical drainage, sepsis, death
Time frame: week 1